Insights & Trends

3824450383_2257d2cac7_z
Image from – Amie Fedora

Here at GLOBALHealthPR, we go to all ends of the earth to deliver recipes for successful global and regional communications programmes to our clients. With offices in more than 40 countries, we know how to find the right mix of local insights and ingredients in order to satisfy the unique tastes and needs of each programme.

In the spirit of the holiday season, we’re sharing some of the traditional recipes that are enjoyed in our local markets around this time of year, delivered by our expert agency partners. Bon Appetit!

 

Americas

Argentina – Vitel Tone

Italian (peidmontese, to be specific) in origin, Vitello Tonnato or Vitel Tone as it’s called in Argentina is a chilled summertime dish traditionally served at Christmas.  Vitel Tone is prepared at least a day in advance, when veal is braised and sliced thin then covered in a thick mayonnaise of tuna with oil and egg yolks, as well as other seasonings. The veal may then be chilled for up to five days to develop the flavour before it is served.

http://www.196flavors.com/2015/12/23/argentina-vitel-tone/

Brazil – Panettone

Panettone is a tall, spongey sweet bread stuffed with candied fruits and raisins, originating in Milan but served at Christmas and the New Year in Brazil, Argentina, Spain and many other countries. Panettone is left to rise for more than 20 hours, giving it the distinctive cupola-like shape. There are a number of colourful myths involving the invention of panettone, ranging from a priest’s love of his hat to a wedding officiated by Leonardo di Vinci.

http://www.myrecipes.com/recipe/panettone-italian-christmas-bread

Canada – Tourtière

A favourite in Quebec and across Canada, tourtière is a meat pie of diced pork or veal of beef. The exact filling depends on what is regionally available. On the coast, fish such as salmon may replace the meats. The slow-cooked deep dish pie may have originated in Quebec, but by the 19th century Quebecois immigrants to the northeastern United States had brought tourtière with them. Beyond differences in meat, some regional variants include potatoes or various spices, and condiments range from ketchup and mustard to maple syrup and mango chutney.

http://blog.kingarthurflour.com/2010/12/17/holiday-baking-traditions-tourtiere/

Mexico – Ponche Navideño

Ponche, a hot punch consisting of local fruits including tejotes, apples, prunes and pears as well as hibiscus, walnuts, raisins and cinnamon, is traditionally served at Christmas Eve celebrations, and the posadas, a nine day celebration leading up to Christmas. Ponche is frequently served warm, but can be chilled to taste, and can include liquor like tequila, rum or brandy for adult holiday festivities.

http://www.themijachronicles.com/2010/12/how-to-make-ponche-the-traditional-mexican-christmas-punch/

United States – Mincemeat Pie

Mincemeat pie originated in the British Isles centuries ago, as crusaders brought back with them spices and recipes for sweet meat and dried fruit pies. Over time, they became a Christmas tradition around the Anglophone world. In the U.S. they are usually eaten as full sized pies, but smaller individual pies are not uncommon. Oftentimes, modern mince pies skip the meat entirely, containing only fruit. Many families will serve the pie with Hard Sauce, so called due to the sherry mixed in with the butter and sugar, hence “hard”.

http://www.foodnetwork.com/recipes/alton-brown/mincemeat-pie-recipe2.html

 

Europe

Denmark – Pickled Herring

Called Inlagd Sil in Danish, pickled herring is traditional holiday fare in Denmark and across the Nordic region and often paired with akvavit, a spiced spirit. Pickled herring has been a northern European tradition since the middle ages and is used as a way to store and transport fish without it spoiling. The herring is served on rye, crispbread, sour cream or potatoes depending on the flavouring given to it during the curing and pickling process, which can include mustard, lingonberries, onion or garlic.

http://honest-food.net/2011/03/08/swedish-pickled-herring/

France – Foie Gras

Foie Gras, as defined by French law, is a duck or goose liver that has been fattened (up to 10 times its natural size) through the forced feeding of corn through a feeding tube. The techniques to force-feed the birds can be traced back all the way to 2500 BCE Egypt. Due to the lengthy and delicate production process, foie gras is considered a dish for special occasions, including Christmas and New Year’s Eve. Traditional French preparations are served cold, but the use of hot preparations has been increasing.

http://www.seriouseats.com/2012/12/the-food-lab-how-to-make-a-foie-gras-torchon.html

Germany – Roast Duck

Duck is the traditional centerpiece of a German Christmas Eve dinner. In addition to the duck, classic sides include red cabbage and potato dumplings. There are two schools of thought on the preparation of duck. Traditionalists cook it low and slow with, celery and apples in the cavity. Alternatively, some cooks simmer the duck in broth and then finish under very high heat in the oven.

http://www.thehungrymouse.com/2009/02/11/the-best-way-to-roast-a-duck-hello-crispy-skin/

Poland – Barszcz

Barszcz is a sour, bright crimson beetroot soup served during the holidays in Poland. Dumplings filled with meats, mushrooms and many other proteins and cheeses are served in the soup as well. The earliest variants of what would come to be known as Barszcz or Borscht were made with hogweed, and later versions would include poppy seeds, almonds, rye brand or barley in addition to the original hogweed and beetroot.

https://medium.com/@mwichary/polish-christmas-hot-beet-soup-with-mushroom-dumplings-663bf22639dc#.bnoic6rn2

Portugal – Bacalhau

Bacalhau is the Portuguese word for salted and dried cod. There are thousands of ways to prepare bacalhau, and yet it is ironically the only fish that is not consumed fresh in Portuguese cuisine. Bacalhau has spread across the Portuguese world, including Cape Verde, Angola, Macau and Brazil. The iconic Christmas recipe for bacalhau is boiled with garlic and served with cabbage, potatoes, carrots and eggs. A friendly note of advice: be sure to soak the bacalhau in water for at least a day before cooking, or else you are in for an extremely salty meal.

http://www.foodnetwork.com/recipes/emeril-lagasse/salt-cod-onions-and-potatoes-bacalhau-a-gomes-de-sa-recipe.html

Spain – Turrón

Turrón is a remarkably simple but delicious sweet treat for the holidays. It consists of only four ingredients: honey, sugar, egg whites and nuts. Together they form a rich nougat, which is cut into bars to be served. The existence of turrón can be traced back to the 15th century. Depending on the amount of nuts and the addition of other ingredients to the core of four, turrón can range from crisp to chewy to the bakers preference.

http://nourishedkitchen.com/turron-de-navidad/

United Kingdom – Christmas pudding

Christmas pudding, sometimes called plum pudding despite the lack of plums (plums were a pre-Victorian term for raisins), can trace its origins back to medieval England. The pudding is made of dried fruits held together by eggs with treacle, or molasses, and flavored with spices and brandy. Because of the high alcohol content, a steamed Christmas pudding can be aged for months, and is sometimes “flamed” or set alight in an electric blue pyrotechnic display to burn off the alcohol and add flavour.

http://www.jamieoliver.com/recipes/fruit-recipes/my-nan-s-christmas-pud-with-vin-santo/

 

Asia Pacific

Australia – Shrimp BBQ

There are few things more iconically Aussie than Shrimp (aka prawns) on the Barbie, and with Christmas coming in Australia’s summer months, it’s only fitting that an outdoor barbeque favourite is also a Christmas tradition. The classic recipe is pretty straightforward: stick the shrimp on the grill and coat with a glaze of garlic, honey, chili sauce and a citrus, though many recipes will call for a little bit of marinating. For dessert, pavlova, a meringue (named after the ballerina) with fruit and whipped cream, is a favourite.

http://www.food.com/recipe/succulent-prawns-for-the-barbie-15548

Hong Kong – Tangyuan

Tangyuan are sweet rice dumplings, that can be served either filled or unfilled and bite sized or large. Fillings include chocolate paste, fruit, peanuts or rock candy, though the most common filling is a paste made of ground black sesame mixed with sugar and lard. The name tangyuan is a homophone in Chinese for union, and as such they are served not only during the traditional Yuanxaio lantern festival and Winter Solstice, but also at family reunions and weddings.

http://www.chinasichuanfood.com/tang-yuan-recipe-black-sesame-filling/

India – Sesame Ladoo

Til Ladoos, or sesame ladoos are a popular treat served around the holiday of Makar Sankranti, celebrating the changing seasons in India and around the world. Ladoos are made from roasted and crushed peanuts, coconut and sesame stuck together with jaggery (cane sugar mixture) caramel. The mixture is then rolled into balls and served warm or at room temperature.

http://www.vegrecipesofindia.com/til-ladoo-recipe-sesame-seeds-laddu/

Singapore – Yu Sheng

Yu Sheng is a raw fish salad with shredded vegetables and condiments popular on the Chinese New Year. Salmon, mackerel and occasionally abalone are popular choices of fish, with the veggies consisting of carrots, radishes, red peppers, turnips, ginger, cabbage and more. Toppings include plum sauce, sesame oil and seeds. Once the dish is made, everyone gathers around the table with their chopsticks and tosses the salad as high as possible. Sometimes called Prosperity Toss, the name itself is a bit of a pun, with Yu Sheng (raw fish – 鱼生) being a homophone for Yu Sheng (prosperity – 余升), a play on both the tossing of the salad and the belief that eating Yu Sheng brings good health and success.

http://www.noobcook.com/yu-sheng-chinese-new-year-raw-fish-salad/

 

We hope you fill your stomachs with great food and your hearts with love and joy this holiday season. Best wishes in 2017 from the GLOBALHealthPR family.

kb-sydney-bridgeI’ve been in Sydney, Australia for just over a week now as a part of the GLOBALHealthPR® Professional Exchange Program. While I’ve done “heaps” of touristy things like check out sweeping views of the city from the Sydney Tower Eye, watched surfers catch some waves at Manly Beach and hung out with koalas at the Wild Life Sydney Zoo, I’ve also gotten a taste of what it’s like to live as a local Aussie. Here are a few things about working with colleagues at our partner agency Team VIVA!  that I wanted to share:

PATIENT FOCUS

I’ve found my work at VIVA! to be highly patient-centric, and find it surprising that a recent Pharma In Focus white paper reports that one in three Australian pharma marketers felt they failed to focus on the patient. Most campaigns include regional or State-specific patient spokespeople who can provide first-hand commentary on what it’s like to live with a certain disease or condition. VIVA! has a real knack for media relations, and develops comprehensive patient case studies, videos and infographics (both still and animated) that are really easy for the media to reference and extract for use in their stories

NO PRODUCT MENTIONS

Under the Medicines Australia Code of Conduct, you cannot mention the names of specific pharmaceutical products or anything that might imply a specific type of treatment in communication to consumers beyond a new product launch, or when the product secures a second indication. So PR and marketing firms need to get creative and find ways to connect with consumers in meaningful ways on behalf of their pharma clients. Programs are often implemented through unrestricted grants to advocacy groups and tend to focus on disease state awareness.

COLLABORATIVE TEAM

VIVA! starts each week with an all-agency meeting. The team works well together, and sometimes it’s all hands on deck. Even the agency’s Principal is not afraid to jump in and help, lending her expertise and experience to all aspects of client service. I’ve also found Australians to be quite direct with each other – no sugar coating feedback or direction – which helps keep projects moving along efficiently and boosts camaraderie within the agency, resulting in the best work for clients.

LIFE IN SYDNEY

The public transport in Sydney is very user-friendly. After only a few days, I was navigating the system like a local. The Opal card, like DC’s SmarTrip or New York’s MetroCard, is really simple to “top up” and each station has easy-to-read digital screens with a clear look at what stops are up next. Plus, the card works seamlessly for the train, bus and ferry systems.

From what I’ve seen, my colleagues and their fellow Sydney residents are a pretty active bunch. Most folks on Team VIVA!  take a walk midday, go for a run after work, or hit the gym a few times a week. Overall, Aussies thrive on the outdoors (who can blame them with the country’s natural beauty and proximity to the beach?), which fuels a healthy outlook on life.

Kaitlin Bowen is participating in the GLOBALHealthPR Professional Exchange Program representing exclusive U.S. partner Spectrum. The Program aims to enhance the connectivity of GLOBALHealthPR agencies through collaboration, best practice sharing, and insights into the drivers that affect health and science communications in different markets worldwide, and to build professional relationships with other GLOBALHealthPR personnel around the globe.

Kaitlin is an account director at GHPR U.S. partner Spectrum. To follow her experiences on the GLOBALHealthPR Professional Exchange Program online, use #GHPRConnects to join the conversation and see all of the 2016 exchange programming.

 

26579376000_690199eccc_k

Today’s post comes to us from Philipp Dieterich, Strategy Expert at GLOBALHealthPR Germany partner, fischerAppelt.

Earlier this year, the German pharma association FSA implemented the Transparency Code, which means that for the first time all pharmaceutical companies in Germany have to publish all monetary contributions they have paid to medical institutions, doctors and other partners throughout the previous year. Technically speaking, this is not a challenging request. However, companies that carry out their duty and publish those numbers let go of the opportunity to establish a new compliance culture and shape communication around it.

It is more than just a bothersome reporting practice:

The pharmaceutical industry claims their monetary contributions serve to transfer knowledge and help improve medical care. Yet the public is skeptical towards pharmaceutical companies  and thus favour the transparent display of pharmaceutical partnerships and financial contributions. Companies that perceive the Transparency Code as a bothersome reporting-practice, and therefore limit their communication to the documentation of their contributions, miss out on a big opportunity. They could be highlighting on collaborative activities and the added value from their cooperation with not only the Transparency Code, but also with the partners they monitarily contribute to. The purpose their contributions should be made clear in terms of what they are serving and how they are advancing the development of pharmaceutical products. This is the main interest of patients and medical associations. This is where communication should start.

There is a need for a new compliance culture:

Future cooperation should be examined more closely to see whether the intended transfer of knowledge results in the improvement of research and medical care. Monetary-only cooperations will be replaced by content-related collaboration. The FSA Transparency Code is a prelude of this change. In the efforts to gain public acceptance and trust, the companies which go beyond regulatory standards will stand out from others. By doing so, they can demonstrate their serious interest in changing the existing structures. The latter is the biggest task as it will significantly impact how different actors collaborate. Consequently, this will lead to a new set of guidelines and rules of compliance.

Communication of change starts now:

In order to actually bring about change in a complex health care system, a comprehensive communication support is indispensable. Companies should actively participate in a constructive public dialogue. This requires being transparent about existing affiliations and their purpose, as well as mediating for future sets of rules. Companies will be evaluated on these points in the upcoming months, and the companies that go beyond communicating just the basics will be among the winners.

 

Recentmedical-marijuana2-630 changes to medicinal marijuana laws and regulations globally have expanded opportunities for medical research and patient care.

These actions are part of a broader global movement of governments and advocates to recognise the potential medicinal benefits of marijuana, which has long been considered solely a harmful recreational drug. These purported medical benefits include aiding in the treatment of  epilepsy, PTSD, chronic pain and more.

Here we present three examples of GLOBALHealthPR member countries – Australia, Canada and the United States – that are tackling the legislative issues surrounding the use of medical marijuana.

Australia:

Last month, New South Wales (NSW) became the first state in Australia to approve legislation that legalises marijuana for medicinal purposes. The Poisons and Therapeutic Goods Act allows doctors to request approval from NSW Health to prescribe medical marijuana to patients who “exhausted standard treatment options.”

The announcement follows extensive trials of marijuana as a medicinal therapy. The Hon. Mike Baird MP hoped to make NSW a global leader in medicinal marijuana research and rallied for it to be accessible for those in need.

“People who are seriously ill should be able to access these medicines if they are the most appropriate next step in their treatment,” said Mr. Baird announcing the legalization of medicinal marijuana on July 31.

The NSW government is also establishing the Centre for Cannabis Research and Innovation, which has been granted $21 million over the next four years to conduct medicinal marijuana trials. Other Australian states, including Queensland, look to follow suit, with multiple trials studying the medicinal benefits of marijuana occurring in the Sunshine State for children living with drug-resistant epilepsy.

Look here to learn more about how medicinal marijuana will be used therapeutically in Australia.

Canada:

Canadian regulations of medicinal marijuana have been in a state of flux over the years. In 2014, the Marijuana for Medical Purposes Regulations (MMPR) established Canada’s first commercial industry of highly-regulated, licensed producers (LPs) of medicinal marijuana, replacing the previous Marijuana Medical Access Regulations (MMAR). To date, 35 LPs are authorised to produce dried marijuana for medical purposes.

In June 2015, the Supreme Court of Canada (R. v. Smith) decided that restricting legal access to only dried marijuana was unconstitutional. As a result, some of these producers are also authorised to produce and sell fresh cannabis and cannabis oil.

The Federal Court of Canada found that “requiring individuals to get their marijuana only from licensed producers violated liberty and security rights protected by section 7 of the Canadian Charter of Rights and Freedoms,” (Allard v. Canada). In response, the Access to Cannabis for Medical Purposes Regulations (ACMPR) replaced MMPR, allowing for limited personal cultivation of marijuana for medical purposes.

Alongside this developing industry, Canada’s current federal government has committed to exploring the legalisation of recreational cannabis. The Task Force on Marijuana Legalization and Regulation was launched in June 2016 and will rely on expert and public consultation to draft recommendations related to this new system. New legislation is anticipated in 2017.

United States:

As of this year, 25 states – as well as the District of Columbia, Guam and Puerto Rico– have legalised marijuana for medicinal use with a recent push in 17 other states to allow a low dosage prescription in limited medical situations.

Despite the progress being made on a state-by-state basis, medicinal marijuana is still in question on an federal level. Last month, the Drug Enforcement Administration (DEA) rejected petitions to remove medicinal marijuana from Schedule I, which rejects marijuana for medicinal use and prohibits doctor prescriptions.

“Marijuana has a legacy reputation. Views are evolving but in the meantime, patients, prescribers and researchers are caught between states that allow medical use of cannabis and the federal government, which maintains that all marijuana use is illegal,” said Al Jackson, EVP Spectrum.

However, the DEA has approved a policy to enact more registered marijuana manufacturers for research purposes. Until this recent change, the University of Mississippi was the only entity in the United States that had the federal license to grow marijuana for medical research.

What’s next?

Long considered a drug that was at best recreational and at worst incredibly harmful, marijuana is starting to see a shift in perceptions as studies are being undertaken to explore its clinical benefits; even big pharma is getting in on the act. One could make the argument that the science is influencing legislation, as studies provide evidence of clinical benefit, more and more governmental bodies are willing to reduce restrictions on the medical use of cannabis. Could this feedback cycle of promising science provide the impetus for medical legalisation in even more countries? Its likely too early to tell, but as seen above, momentum is certainly shifting in favor of fewer restrictions.

What do you think the future of medical marijuana looks like? Sound off in the comments below.

 This blog was a collaborative effort by GLOBALHealthPR Australia partner VIVA! Communications, Canada partner energiPR, and U.S. partner Spectrum.

US_timeline._Prescription_drug_overdose_deaths
The figure above shows the total number of overdose deaths involving prescription medicine from 2001 to 2014 in the U.S. – https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates

For most individuals, the prescriber-patient relationship ends when the prescriber rips off a paper with the patient’s written prescription. As a patient, the moment you see the bottom of your prescription bottle, you know it’s time to take a trip down to the pharmacy to restock the pills. Weeks, months, and even years have passed by and you’re in a cycle of refilling your prescription, with poor communication between you and your prescriber. You may not feel the necessity to call up your prescriber because you feel fine, right? If you don’t experience life-threatening side effects, you must think you’re doing ok.

However, patients can still experience minor impairments in their daily activities that they do not notice or think to mention, which can cause severe health risks in the long-run. In the last 5 years, inappropriate use of pharmaceuticals has dramatically increased. And often, the misuse of prescription drugs tracks back to lack of communication between a patient and prescriber. What are some ways can we prevent prescription misuse, leading to health problems and even death?

Look beyond the prescriber

In an interview with Michelle Gross, Managing Director of Spectrum Science Communications New York Office, I asked for her opinion on whether or not she believes prescribers provide their patients sufficient warning about hazardous interactions between their prescription and OTC medicines or drug and alcohol use. “Patients don’t get enough information about the medicine they are taking and the conditions they have…they need to look beyond the prescriber for ways they could get that information” says Michelle, referring to the fact that prescribers don’t have the time to inform every single one of their patients about the details of each prescription.

Michelle suggested the solution may lie in the prescriber’s care team, like a nurse or a physician’s assistant. Patients could use them as the primary point-of-contact when they have a question about their prescription. Maintaining contact once and a while with a healthcare professional could enhance their knowledge about the drugs they take and provide the opportunity to learn how to prevent misuse.

A potential website portal or app

We use smartphones to connect ourselves with our loved-ones through social media platforms, emailing, and instant messaging. Smartphones and mobile devices have become so deeply ingrained in our social lives, it is hard to imagine what we would do without them.

Michelle asked, “Is there an online google-type resource that could be created where patients could check to get an alert every time their medicine changes? We have the technology to do that, there’s no reason why something like that couldn’t be created.” It doesn’t seem realistic for a physician to be responsible to hold every single one of their patient’s hand and guide them towards their medication process.  If a website portal or an app was created for patients to track their prescription, it could potentially decrease prescription misuse and fit seamlessly into their daily routine.

Inform to enhance

prescription-drug-abuse-us-article1
http://www.coloradomobiledrugtesting.com/opana-newest-prescription-painkiller-being-abused/

Patients and prescribers are busy with their own lives. Neither have time to constantly look out for their
prescriptions or remind one another about important information. However, there is a burden of responsibility on the prescribers, as they are the experts, to properly inform the patient of both the benefits and the risks of taking a drug; this description has to be comprehensive, prescription misuse happens (more often) when patients don’t have the information they need.  Michelle suggests this burden also extends to patients to be open about their personal lives and to update their prescriber on how a particular medication regime is affecting them. Their past challenges, like a drug or alcohol problems, or a family history of adverse reactions to some medications is crucial information for the prescriber when explaining to the patient the benefits and risk factors of a prescription.

Repair our habits

Imagine waking up one morning to a notification from a drug tracker app on your phone informing you that Tylenol can give you severe adverse reactions when taken with your prescribed ADD medicine. You would immediately avoid Tylenol and find an alternate OTC pain reliever to take.  The amount of lives saved would significantly increase if we had the tool to be notified each time our prescription is modified. Prescribers can be more active in encouraging their patients to be responsible and informed about the status and risks of their prescriptions. To prevent incidents of prescription drug misuse, as patients, we must do our parts to responsibly monitor our health while taking prescription medicine and keep our doctors in the loop. By building stronger relationships with our prescribers, we can repair habits of poor communication with one another and properly provide important information about the prescribed medicine and, slowly, but surely, begin to see less prescription misuse.

About the Author:

Fabiana Cuellar is a Public Relations Intern at GLOBALHealthPR

NohepGHPR

At GLOBALHealthPR, we are proud to announce our official support for World Hepatitis Day, July 28, 2016, joining a plethora of organisations fighting to ELIMINATE chronic Hepatitis C. World Hepatitis Day unites people from all walks of life to raise awareness of the substantial global burden of viral hepatitis and to provoke real change in disease prevention, testing and treatment options. The theme for this year’s World Hepatitis Day is ELIMINATION.

Watch the campaign video here.

NoHepInfographic
Get the Infographic

What is Hepatitis C?

Chronic Hepatitis C virus (HCV) is a major global health issue affecting approximately 170 million people worldwide. If left untreated, HCV can progress to cirrhosis (scarring of the liver), liver cancer and liver failure.

HCV is a silent disease – an alarming 95% of people living with viral hepatitis are unaware they have the disease. In May 2016, World Health Organization (WHO) member States that attended the World Health Assembly, Geneva, Switzerland, committed to ELIMINATING viral hepatitis by 2030. The WHO Global Health Sector Strategy (2016-2021) on viral hepatitis aims to reduce the annual death rate from chronic hepatitis from 1.4 million to less than 0.5 million by 2030.

World Hepatitis Day (July 28, 2016) provides an important reminder for families and communities to talk about viral hepatitis and ensure we turn the tide on Hepatitis B and Hepatitis C.

According to Raquel Peck, CEO of the World Hepatitis Alliance, London, UK, “We are at a turning point for viral hepatitis. We have the tools; we have the commitment; what we need now is action. “We are asking all stakeholders to join us in celebrating the launch of NOhep on World Hepatitis Day, to help eliminate viral hepatitis – an illness that affects 400 million people worldwide.”

#Nohep

Nohep is a global World Hepatitis Alliance movement that aims to unite the hepatitis community and broader public to take action and call upon governments to ensure global commitments are met by 2030.

WHY Nohep?

  1. Nohepis RIGHT

4,000 deaths per day is 4,000 too many. Join Nohep… for greater access to life-saving medicines and vaccines

  1. Nohepis SMART

Eliminating hepatitis C will pay for itself by 2030. Join Nohep… to ensure governments make smart investments

  1. Nohep is FOR ALL

Viral hepatitis stigma stops people working, learning and having relationships. Join Nohep… to end stigma and stop discrimination

  1. NohepOUR NEXT GREATEST ACHIEVEMENT

Taking action now will save 7 million lives by 2030. Join Nohep… to make the elimination of viral hepatitis our next greatest achievement.

HOW?

  1. VACCINATE for Nohep

300,000 cancer deaths a year can be prevented. Join Nohep… for universal vaccination coverage.

  1. TEST for Nohep…

95 per cent of people living with viral hepatitis don’t know they are living with the disease. Join Nohep… for increased testing among those at-risk.

  1. TREAT for Nohep…

4,000 people die each day, yet life-saving medicines exist. Join Nohep… for greater access to life-saving treatments.

How can you support World Hepatitis Day?

Great strides have already been made, but so much more can be done to ensure 2016 is the beginning of the end of viral hepatitis. 

To pledge your support to ELIMINATE viral hepatitis:

  1. Sign up to eliminate viral hepatitis by 2030 at http://www.nohep.org/.
  2. Share photos from your events to show the world how you are contributing to the ELIMINATION of viral hepatitis. Upload your photos to http://worldhepatitisday.org/en/gallery or tweet your pictures using #World HepDay.
  3. Sign up to the Nohep Thunderclap before 9:00 am ET at https://www.thunderclap.it/projects/43213-nohep-eliminate-hepatitis to share the following message on your elected social media channels.